亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy

医学 内科学 丙型肝炎 丙型肝炎病毒 人口 免疫学 病毒 环境卫生
作者
Jason Grebely,Gregory J. Dore,Frederick L. Altice,Brian Conway,Alain H. Litwin,Brianna L. Norton,Olav Dalgård,Edward Gane,Oren Shibolet,Ronald Nahass,Anne F. Luetkemeyer,Cheng‐Yuan Peng,David Iser,Isaias Noel Gendrano,Michelle M. Kelly,Peggy Hwang,Ernest Asante‐Appiah,Barbara Haber,Eliav Barr,Michael Robertson,Heather Platt
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:175 (9): 1221-1229 被引量:9
标识
DOI:10.7326/m21-4119
摘要

Background: Hepatitis C virus (HCV) reinfection after successful treatment may reduce the benefits of cure among people who inject drugs. Objective: To evaluate the rate of HCV reinfection for 3 years after successful treatment among people receiving opioid agonist therapy (OAT). Design: A 3-year, long-term, extension study of persons enrolled in the CO-STAR (Hepatitis C Patients on Opioid Substitution Therapy Antiviral Response) study (ClinicalTrials.gov: NCT02105688). Setting: 55 clinical trial sites in 13 countries. Patients: Aged 18 years and older with chronic HCV infection with genotypes 1, 4, or 6 receiving stable OAT. Intervention: No treatments were administered. Measurements: Serum samples were assessed for HCV reinfection. Urine drug screening was performed. Results: Among 296 participants who received treatment, 286 were evaluable for reinfection and 199 were enrolled in the long-term extension study. The rate of HCV reinfection was 1.7 [95% CI, 0.8 to 3.0] per 100 person-years; 604 person-years of follow-up). A higher rate of reinfection was seen among people with recent injecting drug use (1.9 [95% CI, 0.5 to 4.8] per 100 person-years; 212 person-years). Ongoing drug use and injecting drug use were reported by 59% and 21% of participants, respectively, at the 6-month follow-up visit and remained stable during 3 years of follow-up. Limitations: Participants were required to be 80% adherent to OAT at baseline and may represent a population with higher stability and lower risk for HCV reinfection. Rate of reinfection may be underestimated because all participants did not continue in the long-term extension study; whether participants who discontinued were at higher risk for reinfection is unknown. Conclusion: Reinfection with HCV was low but was highest in the first 24 weeks after treatment completion and among people with ongoing injecting drug use and needle–syringe sharing. Primary Funding Source: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
rumengren完成签到 ,获得积分10
21秒前
34秒前
嘉嘉完成签到 ,获得积分10
39秒前
重要元灵完成签到 ,获得积分10
1分钟前
科研通AI2S应助科研通管家采纳,获得10
1分钟前
完美世界应助科研通管家采纳,获得10
1分钟前
俏皮元珊完成签到 ,获得积分10
1分钟前
21完成签到 ,获得积分10
2分钟前
2分钟前
自然芷文发布了新的文献求助10
2分钟前
112345完成签到 ,获得积分10
2分钟前
自然芷文完成签到,获得积分10
3分钟前
3分钟前
迷人问兰发布了新的文献求助10
3分钟前
科研通AI2S应助科研通管家采纳,获得19
3分钟前
sjyu1985完成签到 ,获得积分10
4分钟前
闻巷雨完成签到 ,获得积分10
4分钟前
pegasus0802完成签到 ,获得积分10
4分钟前
5823364完成签到,获得积分10
5分钟前
automan完成签到,获得积分10
5分钟前
天亮polar完成签到,获得积分10
5分钟前
5分钟前
5分钟前
6分钟前
朴实云应发布了新的文献求助10
6分钟前
林子青完成签到,获得积分10
6分钟前
核桃发布了新的文献求助30
6分钟前
李健应助reerwt采纳,获得10
6分钟前
7分钟前
ICSSCI发布了新的文献求助10
7分钟前
7分钟前
刘宇童给刘宇童的求助进行了留言
7分钟前
reerwt发布了新的文献求助10
7分钟前
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
科研通AI2S应助科研通管家采纳,获得10
7分钟前
ICSSCI完成签到,获得积分10
7分钟前
7分钟前
董可以发布了新的文献求助10
8分钟前
风华正茂完成签到,获得积分10
8分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990049
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256369
捐赠科研通 3270998
什么是DOI,文献DOI怎么找? 1805166
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228